While ALT is a marker for liver function [28] and a common predictor of liver cancer risk [4, 5], a number of previous studies have found that ALT tends to decline with aging [14, 15, 29], possibly with stronger effects in males than females [16, 30]. The gene discussed is GPT; the disease is liver cancer.